Jump to content
The World News Media

Health and Medicine

Administrator
  • Posts

    589
  • Joined

  • Last visited

Posts posted by Health and Medicine

  1. images?q=tbn:ANd9GcSseq6kAmB2LmkDx434ALX
    Bidness ETC

    Ocaliva Approved for Rare Liver Disease
    U.S. News & World Report
    TUESDAY, May 31, 2016 (HealthDay News) -- Ocaliva (obeticholic acid) has been approved by the U.S. Food and Drug Administration to treat a rare chronic liver disease called primary biliary cholangitis (PBC). The disease causes the liver's small bile ...
    Intercept Pharma's new liver disease drug comes with hefty price tag: $70000 a yearMarketWatch
    FDA approves Ocaliva for rare, chronic liver diseaseFDA.gov
    New Primary Biliary Cholangitis Treatment ApprovedPharmacy Times
    Bidness ETC -Benzinga -CNA Finance (press release) -PharmaLive (press release) (subscription)
    all 19 news articles »

    Google

  2. images?q=tbn:ANd9GcRlLFC3VO6L2K8Q08kxi43
    KTRS | St Louis News and Talk Radio | The Big 550 AM

    Many children go to primary care for concussions, not the ER
    Clay Center Dispatch
    New research confirms that relying on emergency room data to estimate the prevalence of childhood concussions doesn't deliver a complete picture because many seek treatment in primary care. The study, from the Children's Hospital of Philadelphia health ...
    Primary care is point of entry for many kids with concussions The JAMA Network JournalsEurekAlert (press release)
    Most patients first seek concussion treatment from PCPHealio
    More kids are getting concussions youngerPhilly.com (blog)

    all 6 news articles »

    Google

  3. images?q=tbn:ANd9GcQG0UB01DsX7Ti8bIG5iCZ
    KSDK.com

    Mayor Slay signs prescription drug monitoring bill
    KSDK.com
    Mayor Francis Slay just signed a bill creating the first prescription drug monitoring program in St. Louis. KSDK Staff , KSDK 1:19 PM. CDT May 31, 2016. Prescription drugs (Photo: KSDK). CONNECT TWEET LINKEDIN GOOGLE+ PINTEREST. ST. LOUIS ...
    St. Louis establishes prescription drug monitoring programfox2now.com
    Mayor Slay expected to sign prescription drug monitoring bill TuesdayKMOV.com
    Mayor to sign prescription drug monitoring program in the City of St. LouisKTRS | St Louis News and Talk Radio | The Big 550 AM

    all 8 news articles »

    Google

  4. images?q=tbn:ANd9GcQTXvy88_D-tInLzOu3_Lh
    Medical Xpress

    Scans Spot Brain Region That Misfires in Depressed People
    Philly.com
    TUESDAY, May 31, 2016 (HealthDay News) -- A part of the brain that responds to bad experiences acts in an unexpected way in people with depression, a small study finds. One theory suggested that the pea-sized structure called the habenula was ...
    Brain structure that tracks negative events backfires in depressionEurekAlert (press release)
    Brain Backfires in DepressionI4U News

    all 3 news articles »

    Google

  5. images?q=tbn:ANd9GcRJPbSonp6sXGyAhoQ5X7S
    Palm Beach Post

    Copperhead snake bites child at preschool playground
    Palm Beach Post
    A copperhead snake bit Kiley Cook while she was on a preschool playground. (WFAA/Facebook). Florida statewide building boom follows rollback of regulations. Access to MyPalmBeachPost.com included for Post subscribers. Explore. GRANDBURY, Texas ...
    2-year-old recovering after being bitten by copperhead snake at Granbury day careDallas Morning News (blog)
    Toddler bitten by copperhead at North Texas daycare playgroundWFAA.com
    Granbury toddler bitten by a copperhead snakeWBAP News/Talk

    all 4 news articles »

    Google

  6. images?q=tbn:ANd9GcSK38gjPNXcajUYJIi4-cO
    NOLA.com

    Enrollment for Louisiana's Medicaid expansion opens Wed.
    Washington Times
    BATON ROUGE, La. (AP) - People interested in getting insurance coverage through Louisiana's new Medicaid expansion can begin signing up Wednesday. Residents can apply online at www.healthy.la.gov or by phone at 1-888-342-6207. Gov. John Bel ...
    Louisiana approved for first-in-the-nation Medicaid enrollment planThe Advocate

    all 5 news articles »

    Google

  7. images?q=tbn:ANd9GcRcv4GjgTiymNMiWDpArxN
    MarketWatch

    Intercept Pharma's new liver disease drug comes with hefty price tag: $70000 a year
    MarketWatch
    For the last two decades, there's been little recourse for patients with the rare, chronic disease primary biliary cholangitis — which causes the liver to deteriorate — who didn't respond well to the only treatment option. Those patients, up to 40 ...

    and more »

    Google

  8. images?q=tbn:ANd9GcRcv4GjgTiymNMiWDpArxN
    MarketWatch

    Intercept Pharma's new liver disease drug comes with hefty price tag: $70000 a year
    MarketWatch
    For the last two decades, there's been little recourse for patients with the rare, chronic disease primary biliary cholangitis — which causes the liver to deteriorate — who didn't respond well to the only treatment option. Those patients, up to 40 ...
    Here's Why Intercept Pharma (ICPT) Stock Is Gaining TodayTheStreet.com
    FDA approves Ocaliva for rare, chronic liver diseaseFDA.gov
    New Primary Biliary Cholangitis Treatment ApprovedPharmacy Times
    Bidness ETC -Benzinga -StreetInsider.com -InvestorGuide
    all 19 news articles »

    Google

  9. images?q=tbn:ANd9GcSJE2JTnFy8xQWWZKt372Z
    USA TODAY

    Sisters diagnosed with breast cancer weeks apart
    USA TODAY
    Utah sisters Sharee Page and Annette Page share almost everything, including breast cancer. The siblings found out they had cancer two weeks apart, AP reports. They both have the BRCA2 gene, a mutation that puts a woman at a much greater risk for ...
    Sisters diagnosed weeks apart fight breast cancer togetherWashington Post

    all 11 news articles »

    Google

  10. images?q=tbn:ANd9GcTt7MJOpiePlwHqqhftMrk
    USA TODAY

    Biotech firm StemCells to cease operations
    USA TODAY
    Biotech firm StemCells Inc. plans to dissolve its operations following the failure of a clinical trial that was testing a treatment for spinal cord injury. The Newark, Calif.-based firm said it would assess options to "monetize its intellectual ...
    StemCells, Inc. Announces Termination of Phase II Pathway Study Following Review of DataGlobeNewswire (press release)
    Why StemCells Inc (STEM) Stock Is Cratering TodayInvestorplace.com
    StemCells nixes mid-stage study in spinal cord injury; shares plummet 82%Seeking Alpha
    Sonoran Weekly Review
    all 5 news articles »

    Google

  11. images?q=tbn:ANd9GcSOA8ldrNLw7Vpc2-0024r
    CNA Finance

    FDA approves Ocaliva for rare, chronic liver disease
    FDA.gov
    On Friday, May 27, the U.S. Food and Drug Administration granted accelerated approval for Ocaliva (obeticholic acid) for the treatment of primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UDCA) in adults with an inadequate ...
    Why Intercept Pharmaceuticals Inc (ICPT) is an Attractive Acquisition TargetBidness ETC
    Intercept Pharmaceuticals (ICPT) Stock: FDA Approves OcalivaCNA Finance (press release)
    3 Reasons Goldman Sachs Still Neutral On Intercept PharmaBenzinga
    InvestorGuide -Monthly Prescribing Reference (registration) -Proactive Investors USA & Canada -Wall Street 24
    all 13 news articles »

    Google

  12. images?q=tbn:ANd9GcRVNEKQJLYe1gp9lQja1PM
    Forbes

    Genetic Testing For Cancer Risk Is On The Rise -- But Is It Smart?
    Forbes
    At the upcoming meeting of the American Society of Clinical Oncologists (ASCO), more than 150 presentations are planned on recent discoveries about how genes may predict cancer. The presenters range from health research luminaries like the Mayo Clinic ...
    What's Hot at ASCO 2016?Medscape
    It's not cancer: Removing cancer label from some conditions may greatly improve careGenetic Literacy Project
    Healthy lifestyle reduces risk of common breast cancer genesBioNews
    Kansas City infoZine -Pulse Headlines -Christian Post -ETHealthWorld.com
    all 15 news articles »

    Google

  13. images?q=tbn:ANd9GcRi4QmZWX-JWuk9lzaUWb5
    WTNH Connecticut News (press release)

    Sen. Blumenthal to call for action to fight 'superbugs'
    WTNH Connecticut News (press release)
    HARTFORD, Conn. (WTNH) – U.S. Senator Richard Blumenthal and Dr. Jack Ross, the Director of Infectious Disease at Hartford Hospital, will call for action to fight the spread of antibiotic-resistant bacteria on Tuesday afternoon. For the first time ...

    and more »

    Google

  14. images?q=tbn:ANd9GcQClxM2J7APptK76Ehlc6_
    AllAfrica.com

    Tanzania: HIV Prevalence Data Inaccurate - NBS
    AllAfrica.com
    Dar es Salaam — The current data used for estimating the national HIV prevalence in Tanzania is inaccurate, the National Bureau of Statistics (NBS) revealed yesterday. This means the government has been relying on "inaccurate information" to plan and ...
    New UN treatment targets for HIV/AIDS would be 'expensive but worth every penny'EurekAlert (press release)
    7 HIV Symptoms In WomenCounsel & Heal
    New UN targets for HIV/AIDS treatment expensive, but could save millions of livesYale News
    Deutsche Welle -Daily Times -Xinhua -7thSpace Interactive (press release)
    all 13 news articles »

    Google

  15. images?q=tbn:ANd9GcSqHXdhYj77-0lutUfy3ub
    FierceBiotech

    Teva's Huntington drug launch on hold after FDA rejection
    FierceBiotech
    Teva's $3.5 billion plan to buy Auspex and take the final slap shot needed for a new drug approval has gone awry. The company says that the FDA has rejected its marketing application for SD-809 for chorea, the involuntary motion that afflicts ...
    Teva Pharma (TEVA) Receives CRL from FDA for SD-809; No New Trials RequestedStreetInsider.com
    Teva receives CRL in response to SD-809 NDASeeking Alpha
    FDA Asks Teva for More Information on Huntington's DrugNasdaq
    GuruFocus.com
    all 7 news articles »

    Google

  16. images?q=tbn:ANd9GcTabw61Ps3Va5hpTWEubBX
    Inquirer.net

    EU drug agency: Ecstasy is making a comeback among the young
    Washington Post
    LISBON, Portugal — Ecstasy is becoming popular again in the European Union, with online sales and targeted marketing helping to drive the revival among a new generation of users, the EU drug agency said Tuesday. MDMA, also known as ecstasy, has ...
    Ecstasy in comeback as new generation discovers dance drugThe Guardian
    The internet and MDMA loom large in this year's otherwise unspectacular European Drug ReportDeutsche Welle
    Young users 'guinea pigs' for new wave of drugs: EU watchdogPeninsula On-line

    all 6 news articles »

    Google

  17. images?q=tbn:ANd9GcQCZeuic-fYPpo6Aqgh62G
    UPI.com

    New test helps identify rare genetic diseases in newborns
    UPI.com
    MONDAY, May 30, 2016 -- New gene screening methods may greatly improve doctors' ability to quickly diagnose rare genetic diseases in newborns, researchers say. The new test includes all of the more than 4,800 genes currently known to be linked with ...
    Next-generation gene sequencing helps diagnose rare diseases in newbornsScience Codex

    all 2 news articles »

    Google

×
×
  • Create New...

Important Information

Terms of Service Confirmation Terms of Use Privacy Policy Guidelines We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.